Novacyt Logo

Novacyt

Develops and manufactures molecular diagnostic tests for various health markets.

ALNOV | PA

Overview

Corporate Details

ISIN(s):
FR0010397232 (+1 more)
LEI:
213800BWAC2BF295EG28
Country:
France
Address:
13 AVENUE MORANE SAULNIER, 78129 VELIZY-VILLACOUBLAY

Description

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-16 08:00
Publication of Annual Report
English 21.0 KB
2025-06-16 07:00
Publication du rapport annuel
French 215.8 KB
2025-06-02 12:30
Liquidity Agreement and Total Voting Rights
English 24.3 KB
2025-06-02 12:30
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
French 221.3 KB
2025-05-28 08:00
AGM Voting
English 29.8 KB
2025-05-12 08:00
Notice of AGM
English 21.1 KB
2025-05-02 13:30
Liquidity Agreement Monthly Update and TVR
English 24.3 KB
2025-05-02 12:30
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
French 220.2 KB
2025-04-30 08:00
Full Year 2024 Results
English 586.9 KB
2025-04-30 07:00
Résultats de l'année 2024
French 1.1 MB
2025-04-22 08:00
Notice of Results
English 22.5 KB
2025-04-22 07:00
Avis sur les résultats
French 211.6 KB
2025-04-01 12:45
Liquidity Agreement and Total Voting Rights
English 24.5 KB
2025-04-01 12:45
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
French 217.6 KB
2025-03-18 18:00
Mise à jour relative aux poursuites judiciaires lancées contre Lab 21 par le He…
French 218.7 KB

Automate Your Workflow. Get a real-time feed of all Novacyt filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Novacyt

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Novacyt via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.